Sticking with a winner
Energy Transfer Partners benefits from low interest rates, and a jump in earnings is likely.
Energy Transfer Partners (ETP) has hit my $47 target price just about on schedule. But I don't see any reason to sell these master limited partnership units out of Jubak's Picks quite yet.
As I wrote in July 2009, “the longer the Federal Reserve promises to keep interest rates low, the more valuable Energy Transfer Partners is and the longer I want to hold it.”
The Fed's target for shorter interest rates is still at 0% to 0.25%, and the promise is still to keep rates at that level “for an extended period.”
Long-term interest rates have begun to push upward in anticipation of an eventual change in Fed policy, or inflation, or the depreciation of the dollar, or whatever, but the 7.84% yield on these units is still comfortably ahead of that increase. (For more on Federal Reserve policy, see this post).
So, what's ahead for Energy Transfer Partners?
The partnership has completed or is nearing completion on one set of new pipelines. Those are likely to push earnings before interest, taxes, depreciation and amortization (EBITDA) to $1.8 billion in 2010, according to Standard & Poor's.
That puts the partnership in a position to pursue acquisitions or new capital spending that tie new natural gas production regions such as the Marcellus Shale and Haynesville geologies into its existing pipeline system.
As of Tuesday, I'm raising my target price to $52 a share by November 2010.
At the time of this posting, Jim Jubak owned shares of Energy Transfer Partners in his personal portfolio.
MORE ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
LATEST POSTS
Expect to see more M&A activity involving developers and marketers of antibiotics.
FIDELITY VIEWPOINTS
- How to sell covered calls - Fidelity Investments
- Savvy year-end tax moves to consider now - Fidelity Investments
- Seven ways to prepare for tax changes
- Five reasons an annual review is crucial - Fidelity Investments
- Take a look at mid caps now - Fidelity Investments
- State of the sector: Health care - Fidelity Investments
VIDEO ON MSN MONEY
ABOUT
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
